Pixelgen Technologies Set to Showcase Innovations at ASH Meeting
Pixelgen Technologies, a prominent player in the field of cell surface proteomics, is preparing for an exciting appearance at the upcoming American Society of Hematology (ASH) Annual Meeting. This renowned event is scheduled at the San Diego Convention Center, where Pixelgen will unveil new advancements in their patented Molecular Pixelation (MPX) technology. Their participation marks a significant milestone as they explore applications of this technology in the realm of hematology.
The ASH Annual Meeting represents a vital opportunity for Pixelgen to share how spatial mapping of cell surface proteins can enhance research in hematology. According to Simon Fredriksson, PhD and CEO of Pixelgen, this technology enables researchers to derive unprecedented insights into protein organization and complex interactions that are crucial for understanding blood cell functions and related diseases. The excitement surrounding this event stems from its potential to contribute considerably to diagnostics and personalized therapeutic options.
Innovation in Hematology Research
Innovation is at the forefront of Pixelgen's mission, and this event will highlight two pivotal presentations that showcase the capabilities of their technology:
- Dr. Fredriksson is set to deliver an industry presentation centered on "The Spatial Organization of Surface Proteins of Single Cells in Myelodysplastic Syndrome for Diagnostics and Drug Target Discovery By Molecular Pixelation." This will feature collaborative data prepared by Dr. Aaron Viny from Columbia University, scheduled for December 7, from 3:30 to 3:45 p.m. in Room 5B.
- Dr. Jessica Nordlund from Uppsala University will present a poster titled "Mapping the Spatial Proteome of Individual Leukemia Cells Undergoing Fludarabine Treatment." This session will take place on December 7, from 5:30 to 9:30 p.m., in Halls G-H.
Attendees at the ASH meeting can also find Pixelgen at Booth #2852, where representatives will demonstrate their latest product offerings and discuss recent findings regarding the identification of CAR-T cells and their cell surface proteome. One highlight to note is a newly developed Application Note, crafted in collaboration with Illumina, which showcases cancer-specific protein patterns in blood cancer cells.
About Pixelgen Technologies
Founded in 2020, Pixelgen Technologies AB has committed itself to transforming biological research through cutting-edge visualization technologies. Their Molecular Pixelation platform allows scientists to analyze cell surface proteins more deeply, leading to innovative insights that can fuel advancements in medicine and diagnostics.
Based in Stockholm, Sweden, Pixelgen continues to push the boundaries of scientific inquiry by mapping cellular interactions and advancing knowledge that can enhance treatment outcomes across hematological diseases.
Frequently Asked Questions
What is the primary focus of Pixelgen Technologies at the ASH meeting?
Pixelgen Technologies aims to showcase their patented Molecular Pixelation technology and its implications for research in hematology at the ASH Annual Meeting.
Who will represent Pixelgen Technologies at the ASH event?
CEO Simon Fredriksson will present alongside several collaborators, including Dr. Aaron Viny from Columbia University and Dr. Jessica Nordlund from Uppsala University.
What type of presentations will Pixelgen feature?
Pixelgen will feature an industry presentation and a poster session, highlighting important research involving cell surface proteins and their applications in hematological conditions.
Where can attendees find Pixelgen at the ASH meeting?
Attendees can visit Pixelgen Technologies at Booth #2852 to learn more about their products and recent scientific advancements.
What innovative methods does Pixelgen use for biological research?
Pixelgen employs Molecular Pixelation, a DNA-based visualization technology that aids in analyzing cell surface proteins to discover new insights into cellular activities.
